Cat.No.:

IC-0225779

Product Information

Biological Activity

Berberine is the main active component of Coptis chinensis French, which has been used to treat diabetes for thousands of years. Type 2 diabetes is a worldwide health threat and its treatment is limited by availability of effective medications. All of the existing oral hypoglycemic agents have subsequent failure after long term administration.
In vitro: Berberine was found to be able to increase the glucose consumption and/or glucose uptake in the absence of insulin in adipocytes, hepatocytes and myotubes. The enhancing glucose metabolism of berberine might be due to glycolysis stimulation, which was related to the mitochondria oxidation inhibition. Berberine might also act as an alpha-glucosidase inhibitor. In addition, berberine inhibited activities of disaccharidases and decreased glucose transportation cross the intestinal epithelium [1].
In vivo: In diet-induced obese rats, berberine was found to reduce insulin resistance, similar to metformin. Berberin and metformin improved insulin resistance and liver glycogen level in insulin resistance models, but had no effect on insulin, blood glucose, lipid levels and muscle triglyceride depots [2].
Clinical trial: A pilot study was conducted to determine the efficacy and safety of berberine in the treatment of type 2 diabete. The hypoglycemic effect of berberine was found to be similar to that of metformin. Significant decreases in fasting blood glucose, hemoglobin A1c, plasma triglycerides and postprandial blood glucose were observed in the berberine treatment group [1].

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

Species

Mouse

Rat

Rabbit

Guinea pig

Hamster

Dog

Weight (kg)

0.02

0.15

1.8

0.4

0.08

10

Body Surface Area (m2)

0.007

0.025

0.15

0.05

0.02

0.5

Km factor

3

6

12

8

5

20

Animal A (mg/kg) = Animal B (mg/kg) multiplied by  (Animal B Km / Animal A Km)
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Order Information

Quantity

Price($)

Price($)

Availability

500mg

$120.00

€144.00

In stock

1g

$180.00

€216.00

In stock

5g

$400.00

€462.00

In stock

Free Delivery on orders over $350.00.

Chemical Information

Molecular Weight

371.81

Formula

C20H18ClNO4

CAS Number

633-65-8

Purity

>99.00%

Solubility

¡Ý 18.6mg/mL in DMSO with gentle warming

Storage

at 2-8¡ãC

Reference

[1]. Yin J,Xing H,Ye J.  Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism.2008 May;57(5):712-7.

[2]. Gao CR,Zhang JQ,Huang QL.  Experimental study on berberin raised insulin sensitivity in insulin resistance rat models. Zhongguo Zhong Xi Yi Jie He Za Zhi.1997 Mar;17(3):162-4.

We Devoted Ourselves To The Development Of Biomedical Research Reagent.